Control of left ventricular mass by moxonidine involves reduced DNA synthesis and enhanced DNA fragmentation.
Autor: | Paquette, P-A.1, Duguay, D.2, Ayoubi, R. El-1, Menaouar, A.1, Danalache, B.1, Gutkowska, J.1, DeBlois, D.2, Mukaddam-Daher, S.1 suhayla.mukaddam-daher@umontreal.ca, El-Ayoubi, R (AUTHOR) |
---|---|
Zdroj: | British Journal of Pharmacology. Feb2008, Vol. 153 Issue 3, p459-467. 9p. 1 Chart, 6 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |